Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cells.
Zikry TM, Wolff SC, Ranek JS, Davis HM, Naugle A, Luthra N, Whitman AA, Kedziora KM, Stallaert W, Kosorok MR, Spanheimer PM, Purvis JE.
Zikry TM, et al. Among authors: spanheimer pm.
Proc Natl Acad Sci U S A. 2024 Feb 13;121(7):e2309261121. doi: 10.1073/pnas.2309261121. Epub 2024 Feb 7.
Proc Natl Acad Sci U S A. 2024.
PMID: 38324568
Free PMC article.